Near-infrared fluorescence catheter system for two-dimensional intravascular imaging in vivo

Optics Express

Volumn 18, Issue 11, 2010, Pages 11372-11381

  Nika Razansky, R ^a   Rosenthal, Amir ^a,b   Mallas, George ^b   Razansky, Daniel ^a   Jaffer, Farouc A ^b   Ntziachristos, Vasilis ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD PRESSURE; CATHETERS; FLUORESCENCE; HEART; INFRARED DEVICES; MACHINE DESIGN; TWO DIMENSIONAL; VISUALIZATION;

CARDIAC CATHETERIZATIONS; CORONARY ARTERIES; FIBER DESIGN; FLUORESCENCE ACTIVITY; FLUORESCENCE IMAGE; IN-VIVO; INTRAVASCULAR; INTRAVASCULAR IMAGING; MOLECULAR IMAGING; NEAR-INFRARED FLUORESCENCE; PERFORMANCE METRICS; ROTATIONAL AXIS; SEAMLESS INTEGRATION;

BLOOD VESSELS;

ARTERY; ARTICLE; CATHETERIZATION; ENDOSCOPE; EQUIPMENT; EQUIPMENT DESIGN; FLUORESCENCE MICROSCOPY; HISTOLOGY; HUMAN; INFRARED RADIATION; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ARTERIES; CATHETERIZATION, PERIPHERAL; ENDOSCOPES; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; INFRARED RAYS; MICROSCOPY, FLUORESCENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77952836364     PISSN: None     EISSN: 10944087     Source Type: Journal    
DOI: 10.1364/OE.18.011372     Document Type: Article

References (25)

1. Z. A. Fayad, and V. Fuster, "Clinical imaging of the high-risk or vulnerable atherosclerotic plaque," Circ. Res. 89 (4), 305-316 (2001).
2. M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, Z. Fayad, P. H. Stone, S. Waxinan, P. Raggi, M. Madjid, A. Zarrabi, A. Burke, C. Yuan, P. J. Fitzgerald, D. S. Siscovick, C. L. de Korte, M. Aikawa, K. E. Juhani Airaksinen, G. Assmann, C. R. Becker, J. H. Chesebro, A. Farb, Z. S. Galis, C. Jackson, I. K. Jang, W. Koenig, R. A. Lodder, K. March, J. Demirovic, M. Navab, S. G. Priori, M. D. Rekhter, R. Bahr, S. M. Grundy, R. Mehran, A. Colombo, E. Boerwinkle, C. Ballantyne, W. Insull, Jr., R. S. Schwartz, R. Vogel, P. W. Serruys, G. K. Hansson, D. P. Faxon, S. Kaul, H. Drexler, P. Greenland, J. E. Muller, R. Virmani, P. M. Ridker, D. P. Zipes, P. K. Shah, and J. T. Willerson, "From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I," Circulation 108 (14), 1664-1672 (2003).
3. J. A. Schaar, F. Mastik, E. Regar, C. A. den Uil, F. J. Gijsen, J. J. Wentzel, P. W. Serruys, and A. F. W. van der Stehen, "Current diagnostic modalities for vulnerable plaque detection," Curr. Pharm. Des. 13 (10), 995-1001 (2007).
4. P. H. Tran, D. S. Mukai, M. Brenner, and Z. P. Chen, "In vivo endoscopic optical coherence tomography by use of a rotational microelectromechanical system, probe," Opt. Lett. 29 (11), 1236-1238 (2004).
5. S. Waxman, F. Ishibashi, and J. E. Muller, "Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events," Circulation 114 (22), 2390-2411 (2006).
6. B. D. MacNeill, H. C. Lowe, M. Takano, V. Fuster, and I. K. Jang, "Intravascular modalities for detection of vulnerable plaque: current status," Arterioscler. Thromb. Vase. Biol. 23 (8), 1333-1342 (2003).
7. P. Libby, "Inflammation in atherosclerosis," Nature 420 (6917), 868-874 (2002).
8. G. K. Hansson, "Inflammation, atherosclerosis, and coronary artery disease - Reply," N. Engl. J. Med. 353 (4), 429-430 (2005).
9. F. A. Jaffer, P. Libby, and R. Weissleder, "Molecular and cellular imaging of atherosclerosis: emerging applications," J. Am. Coll. Cardiol. 47 (7), 1328-1338 (2006).
10. F. A. Jaffer, P. Libby, and R. Weissleder, "Molecular imaging of cardiovascular disease," Circulation 116 (9), 1052-1061 (2007).
11. J. Sanz, and Z. A. Fayad, "Imaging of atherosclerotic cardiovascular disease," Nature 451 (7181), 953-957 (2008).
12. F. A. Jaffer, P. Libby, and R. Weissleder, "Optical and multimodality molecular imaging: insights into atherosclerosis," Arterioscler. Thromb. Vase. Biol. 29 (7), 1017-1024 (2009).
13. F. A. Jaffer, C. Vinegoni, M. C. John, E. Aikawa, H. K. Gold, A. V. Finn, V. Ntziachristos, P. Libby, and R. Weissleder, "Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis, " Circulation 118 (18), 1802-1809 (2008).
14. V. Ntziachristos, C.-H. Tung, C. Bremer, and R. Weissleder, "Fluorescence molecular tomography resolves protease activity in vivo," Nat. Med. 8 (7), 757-761 (2002).
15. V. Ntziachristos, J. Ripoll, L. V. Wang, and R. Weissleder, "Looking and listening to light: the evolution of whole-body photonic imaging," Nat. Biotechnol. 23 (3), 313-320 (2005).
16. B. Zhu, F. Jaffer, V. Ntziachristos, and R. Weissleder, "Development of a near infrared fluorescence catheter: operating characteristics and feasibility for atherosclerotic plaque detection," J. Phys. D Appl. Phys. 38 (15), 2701-2707 (2005).
17. W. Cheong, S. Prahl, and A. Welch, "A review of the optical properties of biological, tissues," IEEE J. Quantum Electron. 26 (12), 2166-2185 (1990).
18. V. Ntziachristos, J. Ripoll, and R. Weissleder, "Would near-infrared fluorescence signals propagate through large human organs for clinical studies?" Opt. Lett. 27 (5), 333-335 (2002).
19. M. Haller, C. Akbulut, H. Brechtelsbauer, W. Fett, J. Briegel, U. Finsterer, and K Peter, "Determination of plasma volume with indocyanine green in man," Life Sci. 53 (21), 1597-1604 (1993).
20. Q. S. Sheng, R. Lang, Q. He, Y. J. Yang, D. F. Zhao, and D. Z. Chen, "Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis," Hepatobiliary Pancreat. Dis. Int. 8 (1), 46-49 (2009).
21. M. Reekers, M. J. G. Simon, F. Boer, R. A. G. Mooren, J. W. van Kleef, A. Dahan, and J. Vuyk, "Cardiovascular monitoring by pulse dye densitometry or arterial indocyanine green dilution," Anesth. Analg. 109 (2), 441-446 (2009).
22. M. Sekimoto, M. Fukui, and K. Fujita, "Plasma volume estimation using indocyanine green with biexponential regression analysis of the decay curves," Anaesthesia 52 (12), 1166-1172 (1997).
23. M. Jacob, P. Conzen, U. Finsterer, A. Krafft, B. F. Becker, and M. Rehm, "Technical and physiological background of plasma volume measurement with indocyanine green: a clarification of misunderstandings," J. Appl. Physiol. 102 (3), 1235-1242 (2006).
24. D. Hyde, R. de Kleine, S. A. MacLaurin, E. Miller, D. H. Brooks, T. Krucker, and V. Ntziachristos, "Hybrid FMT-CT imaging of amyloid-beta plaques in a murine Alzheimer's disease model," Neuroimage 44 (4), 1304-1311 (2009).
25. P. K. Yalavarthy, B. W. Pogue, H. Dehghani, and K. D. Paulsen, "Weight-matrix structured regularizaron provides optimal generalized least-squares estimate in diffuse optical tomography," Med. Phys. 34 (6), 2085-2098 (2007).